This conjoint finding of highest SFRP4 expression in tubal epithelium and lowest in Type II ovarian cancers fits optimally to the proposed model that Type II cancers derive rather from the tubal epithelium and not the ovarian surface epithelium. This evidence concerns the gene SFRP4 and ovarian cancer.